NST Stock Overview
Engages in the manufacture, distribution, and sale of mobile telemedical solution under the Pregnabit brand. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Nestmedic S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.61 |
| 52 Week High | zł1.44 |
| 52 Week Low | zł0.50 |
| Beta | -0.032 |
| 1 Month Change | 4.48% |
| 3 Month Change | -3.50% |
| 1 Year Change | -56.40% |
| 3 Year Change | -70.00% |
| 5 Year Change | -29.53% |
| Change since IPO | -96.08% |
Recent News & Updates
Shareholder Returns
| NST | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -10.4% | -2.9% | -2.5% |
| 1Y | -56.4% | -28.5% | -4.9% |
Return vs Industry: NST underperformed the Polish Medical Equipment industry which returned -28.5% over the past year.
Return vs Market: NST underperformed the Polish Market which returned -4.9% over the past year.
Price Volatility
| NST volatility | |
|---|---|
| NST Average Weekly Movement | 9.4% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in PL Market | 8.7% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: NST's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: NST's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 6 | Jacek Gnich | www.nestmedic.com |
Nestmedic S.A., together with its subsidiaries, engages in the manufacture, distribution, and sale of mobile telemedical solution under the Pregnabit brand. The company offers Pregnabit and Pregnabit Pro medical devices operating in a telediagnostic model that support the work of doctors and midwives in measuring fetal heart rate and uterine contraction activity, as well as signaling fetal movements for monitoring fetal and maternal well-being in the final weeks of pregnancy. It also provides Pregnabit Cloud, a software as a service system designed to work with telemedical cardiotocography examination devices implementing the required communication protocol to send measurement data during an examination; and PregnaView, a component of the Pregnabit system that functions as a separate medical device.
Nestmedic S.A. Fundamentals Summary
| NST fundamental statistics | |
|---|---|
| Market cap | zł17.90m |
| Earnings (TTM) | -zł5.79m |
| Revenue (TTM) | zł669.71k |
26.7x
P/S Ratio-3.1x
P/E RatioIs NST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NST income statement (TTM) | |
|---|---|
| Revenue | zł669.71k |
| Cost of Revenue | zł196.27k |
| Gross Profit | zł473.44k |
| Other Expenses | zł6.26m |
| Earnings | -zł5.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 70.69% |
| Net Profit Margin | -864.73% |
| Debt/Equity Ratio | 135.4% |
How did NST perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 00:03 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nestmedic S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |